News Focus
News Focus
Replies to #76926 on Biotech Values
icon url

srsmgja

04/30/09 8:30 AM

#76943 RE: pharmaclown35 #76926

Merck KGaA Oral Drug Effective, Cancer Mat Raise Concern By Thomas Gryta, of Dow Jones Newswire

"Notably, four patients in the Cladribine group developed cancer during the study and another case emerged 6 months after the study ended."